New diabetes meds may shield eyes from vision loss
Disease control
Recruiting now
This study tests whether newer diabetes drugs (SGLT2 inhibitors and DPP-4 inhibitors) can delay or prevent diabetic retinopathy, an eye disease that can lead to vision loss. Researchers will compare these newer drugs to older treatments in 70 people with type 2 diabetes. The goal…
Sponsor: Sara A Belal • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC